|Articles|September 1, 2002
- Applied Clinical Trials-09-01-2002
Using Adaptive Interim Analysis to Calculate Sample Size in a Trial of a Treatment for Erectile Dysfunction
Adaptive interim analysis may allow smaller sample sizes when a drug?s clinical effect is unknown.
Advertisement
Articles in this issue
almost 24 years ago
EU as Physician Rather than Police Officeralmost 24 years ago
Radiology in Oncology Trials: Critical Success Factorsalmost 24 years ago
Changing Current Practicealmost 24 years ago
Coping with the Cost of Prescription Benefitsalmost 24 years ago
EORTC's Regulatory Affairs Unitalmost 24 years ago
Building and Maintaining Monitor-Coordinator Relationshipsalmost 24 years ago
Ethnicity in Drug Development and TherapeuticsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Artificial Intelligence in Clinical Trials: From Pilots to Practice
2
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
5